Session Type
Meeting
Search Results for LOS
Abstract Number: 228
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Rifaximin 550 mg tablets is a nonsystemic antibiotic indicated for reducing the risk of overt hepatic encephalopathy (OHE) recurrence in adults and may be used alone or in combination with the cathartic lactulose. This analysis evaluated the safety profile of rifaximin alone vs rifaximin + lactulose (combination) in patients with cirrhosis. Methods: In a […]
Abstract Number: 230
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: As a group of medical students in a five-week leadership program, we were charged with making a medicine inpatient unit at an urban quaternary care academic medical center the best unit in the hospital. Research shows that the hospital spends an estimated $2721 for every inpatient day (Kaiser, AHA Annual Survey, 2015). Longer lengths […]
Abstract Number: 230
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Guidelines on the treatment of Clostridioides (Clostridium) difficile infection (CDI) have historically recommended avoiding antimotility agents (AAs) in patients with active CDI based on theoretical concerns that administration of AAs may precipitate serious adverse events such as toxic megacolon in these patients. These recommendations, however, are based on limited and conflicting data. We previously […]
Abstract Number: 232
Hospital Medicine 2020, Virtual Competition
Background: Penicillin class antibiotics are the most frequently reported drug allergy in the electronic health record (EHR), but recent studies find
Abstract Number: 233
SHM Converge 2024
Background: The leadership of our academic hospital medicine group designed a geographic rounding intervention with the goal of improving patient-nursing communication, decreasing hurdles in discharging patients and eventually leading to reducing patient length of stay and increasing discharge rate. Our quantitative analysis compared the pre-intervention and post-intervention time periods with regard to observed to expected […]
Abstract Number: 235
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Clostridioides difficile infection (CDI) can be prevented through infection prevention practices and antibiotic stewardship. We found in a 2013 national survey (571 hospitals, 71% response rate) that while infection prevention practices for CDI were common in U.S. hospitals, only 52% had an antibiotic stewardship program (ASP). On 1 January 2017, The Joint Commission required […]
Abstract Number: 238
SHM Converge 2023
Background: The importance of accurate patient care records for effective communication and medical education is well documented. However, medical documentation as a tool for financial compensation is not emphasized in graduate medical education. We performed a review and analysis of resident charting errors during inpatient rotations to determine the potential revenue loss and economic impact. […]
Abstract Number: 265
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There are 400,000 cases and 30,000 deaths from Clostridium difficile (C. diff) infections in the United States annually. Efforts to reduce the transmission of C. diff have focused on patients with diarrhea, however, many patients with C. diff are carriers who do not have symptoms. Because they are not isolated, carriers serve as a […]
Abstract Number: 266
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Timely Clostridium difficile Infection (CDI) testing is challenging but is important for faster and appropriate isolation and treatment of patients. Few studies have specifically addressed effective methods to hasten CDI testing without relying on PCR. We sought to use Quality Improvement methodologies including the Plan-Do-Study-Act (PDSA) Cycle and Control Charts to reduce CDI testing […]
Abstract Number: 268
Hospital Medicine 2020, Virtual Competition
Background: Clostridium difficile infections (CDI) is the most common cause of healthcare-associated infections in the United States. CDI accounts for 15%- 25% of all cases of nosocomial diarrhea. CDI is associated with significant adverse outcomes such as higher inpatient mortality rate, a longer length of hospital stays and increased hospital costs. The incidence of Hospital-acquired […]